China Health Group Inc. (FRA:VNL1)

Germany · Delayed Price · Currency is EUR

0.0005

0.00 (0.00%)

Last updated: Sep 3, 2026, 9:47 AM CEST

Market Cap	7.82M -55.6%
Revenue (ttm)	3.85M +0.4%
Net Income	-1.83M
EPS	-0.00
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.0005
Previous Close	0.0005
Day's Range	0.0005 - 0.0005
52-Week Range	0.0005 - 0.0080
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 10, 2026

About China Health Group

China Health Group Inc., together with its subsidiaries, researches and develops bio, natural, and synthetic drugs in the People’s Republic of China. It engages in the pharmacodynamics and clinical research of drugs; provision of post market and contracted pharmaceutical development services; and technological transfer and services for the research and development of drugs. The company was formerly known as Venturepharm Laboratories Limited and changed its name to China Health Group Inc. in February 2015. China Health Group Inc. was founded in ... [Read more]

Industry Diagnostics & Research

Sector Healthcare

Founded 1998

Employees 33

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol VNL1

Financial Performance

In 2025, China Health Group's revenue was 28.56 million, an increase of 7.98% compared to the previous year's 26.45 million. Losses were -14.96 million, 3.05% more than in 2024.

Financial numbers in CNY Financial Statements